Çoban Ş - Search Results

1

Tenofovir-best hope for treatment of chronic hepatitis B infection?

Örmeci N, Özbaş B, Güner R, Özkan H, Yalçı A, Çoban Ş, Dökmeci A, Kalkan Ç, Akıncı H, Yüksel O, Başar Ö, Yüksel İ, Balık İ. Örmeci N, et al. Among authors: coban s. Turk J Gastroenterol. 2015 Jul;26(4):322-7. doi: 10.5152/tjg.2015.0164. Epub 2015 Jun 2. Turk J Gastroenterol. 2015. PMID: 26038999 Free article.

2

Pegylated interferon alfa-2B for chronic delta hepatitis: 12 versus 24 months.

Ormeci N, Bölükbaş F, Erden E, Coban S, Ekiz F, Erdem H, Palabıyıkoğlu M, Beyler AR, Balık I, Bölükbaş C, Nazlıgül Y, Köklü S. Ormeci N, et al. Among authors: coban s. Hepatogastroenterology. 2011 Sep-Oct;58(110-111):1648-53. doi: 10.5754/hge10126. Hepatogastroenterology. 2011. PMID: 22086695 Clinical Trial.

3

Is there an association between the measurement of qualitative HBsAg and virologic response in chronic HBV infection?

Altinbas A, Aktas B, Basar O, Yüksel O, Ekiz F, Yilmaz B, Coban S. Altinbas A, et al. Among authors: coban s. Ann Hepatol. 2012 May-Jun;11(3):320-5. Ann Hepatol. 2012. PMID: 22481449 Free article.

4

Amantadine in non-responder patients with chronic hepatitis C: a randomized prospective study.

Palabıyıkoğlu M, Ormeci N, Ekiz F, Beyler AR, Erdem H, Dökmeci A, Ozkan H, Köklü S, Coban S. Palabıyıkoğlu M, et al. Among authors: coban s. Hepatogastroenterology. 2012 Sep;59(118):1911-4. doi: 10.5754/hge10341. Hepatogastroenterology. 2012. PMID: 22819912 Clinical Trial.

5

Long-term efficacy and safety of lamivudine, entecavir, and tenofovir for treatment of hepatitis B virus-related cirrhosis.

Köklü S, Tuna Y, Gülşen MT, Demir M, Köksal AŞ, Koçkar MC, Aygün C, Coban S, Ozdil K, Ataseven H, Akin E, Pürnak T, Yüksel I, Ataseven H, Ibiş M, Yildirim B, Nadir I, Küçükazman M, Akbal E, Yüksel O, Başar O, Alkan E, Baykal O. Köklü S, et al. Among authors: coban s. Clin Gastroenterol Hepatol. 2013 Jan;11(1):88-94. doi: 10.1016/j.cgh.2012.10.003. Epub 2012 Oct 9. Clin Gastroenterol Hepatol. 2013. PMID: 23063679

6

Atypical presentation of hepatocellular carcinoma: a mass on the left thoracic wall.

Coban S, Yüksel O, Köklü S, Ceyhan K, Baykara M, Dökmeci A. Coban S, et al. BMC Cancer. 2004 Dec 1;4:89. doi: 10.1186/1471-2407-4-89. BMC Cancer. 2004. PMID: 15574203 Free PMC article.

7

The significance of serum transforming growth factor beta 1 in detecting of gastric and colon cancers.

Coban S, Yüksel O, Koçkar MC, Köklü S, Basar O, Tutkak H, Ormeci N. Coban S, et al. Hepatogastroenterology. 2007 Jul-Aug;54(77):1472-6. Hepatogastroenterology. 2007. PMID: 17708279

8

Mean platelet volume as a fibrosis marker in patients with chronic hepatitis B.

Ekiz F, Yüksel O, Koçak E, Yılmaz B, Altınbaş A, Çoban S, Yüksel I, Üsküdar O, Köklü S. Ekiz F, et al. Among authors: coban s. J Clin Lab Anal. 2011;25(3):162-5. doi: 10.1002/jcla.20450. J Clin Lab Anal. 2011. PMID: 21567462 Free PMC article.

9

Non-invasive tests in prediction of liver fibrosis in chronic hepatitis B and comparison with post-antiviral treatment results.

Başar O, Yimaz B, Ekiz F, Giniş Z, Altinbaş A, Aktaş B, Tuna Y, Çoban S, Delibaş N, Yüksel O. Başar O, et al. Among authors: coban s. Clin Res Hepatol Gastroenterol. 2013 Apr;37(2):152-8. doi: 10.1016/j.clinre.2012.07.003. Epub 2013 Feb 4. Clin Res Hepatol Gastroenterol. 2013. PMID: 23391746

10

APRI, the FIB-4 score, and Forn's index have noninvasive diagnostic value for liver fibrosis in patients with chronic hepatitis B.

Ucar F, Sezer S, Ginis Z, Ozturk G, Albayrak A, Basar O, Ekiz F, Coban S, Yuksel O, Armutcu F, Akbal E. Ucar F, et al. Among authors: coban s. Eur J Gastroenterol Hepatol. 2013 Sep;25(9):1076-81. doi: 10.1097/MEG.0b013e32835fd699. Eur J Gastroenterol Hepatol. 2013. PMID: 23510962

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

252 results

Search Page